175 related articles for article (PubMed ID: 11905954)
1. Isoflavones, substances with multi-biological and clinical properties.
Ren MQ; Kuhn G; Wegner J; Chen J
Eur J Nutr; 2001 Aug; 40(4):135-46. PubMed ID: 11905954
[TBL] [Abstract][Full Text] [Related]
2. Soy protein, isoflavones and cardiovascular disease risk.
Lichtenstein AH
J Nutr; 1998 Oct; 128(10):1589-92. PubMed ID: 9772121
[TBL] [Abstract][Full Text] [Related]
3. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.
Sirtori CR
Drug Saf; 2001; 24(9):665-82. PubMed ID: 11522120
[TBL] [Abstract][Full Text] [Related]
4. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee.
Sacks FM; Lichtenstein A; Van Horn L; Harris W; Kris-Etherton P; Winston M;
Circulation; 2006 Feb; 113(7):1034-44. PubMed ID: 16418439
[TBL] [Abstract][Full Text] [Related]
5. Soy for cardiovascular indications.
Chester EA
Am J Health Syst Pharm; 2001 Apr; 58(8):663, 666. PubMed ID: 11329758
[No Abstract] [Full Text] [Related]
6. A review of the animal models used to investigate the health benefits of soy isoflavones.
Cooke GM
J AOAC Int; 2006; 89(4):1215-27. PubMed ID: 16918038
[TBL] [Abstract][Full Text] [Related]
7. Prevention of retinoic acid-induced osteoporosis in mice by isoflavone-enriched soy protein.
Yang J; Wu N; Peng J; Yang X; Guo J; Yin S; Wang J
J Sci Food Agric; 2016 Jan; 96(1):331-8. PubMed ID: 25645024
[TBL] [Abstract][Full Text] [Related]
8. Soy protein and cardiovascular disease: the impact of bioactive components in soy.
Potter SM
Nutr Rev; 1998 Aug; 56(8):231-5. PubMed ID: 9735676
[TBL] [Abstract][Full Text] [Related]
9. Soybean foods and their benefits: potential mechanisms of action.
Omoni AO; Aluko RE
Nutr Rev; 2005 Aug; 63(8):272-83. PubMed ID: 16190314
[TBL] [Abstract][Full Text] [Related]
10. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
North American Menopause Society
Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
[TBL] [Abstract][Full Text] [Related]
11. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats.
Arjmandi BH; Getlinger MJ; Goyal NV; Alekel L; Hasler CM; Juma S; Drum ML; Hollis BW; Kukreja SC
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1358S-1363S. PubMed ID: 9848499
[TBL] [Abstract][Full Text] [Related]
12. Long-term intake of soy protein improves blood lipid profiles and increases mononuclear cell low-density-lipoprotein receptor messenger RNA in hypercholesterolemic, postmenopausal women.
Baum JA; Teng H; Erdman JW; Weigel RM; Klein BP; Persky VW; Freels S; Surya P; Bakhit RM; Ramos E; Shay NF; Potter SM
Am J Clin Nutr; 1998 Sep; 68(3):545-51. PubMed ID: 9734729
[TBL] [Abstract][Full Text] [Related]
13. Biological Effect of Soy Isoflavones in the Prevention of Civilization Diseases.
Pabich M; Materska M
Nutrients; 2019 Jul; 11(7):. PubMed ID: 31330799
[TBL] [Abstract][Full Text] [Related]
14. Phyto-oestrogens and cardiovascular disease risk.
van der Schouw YT; de Kleijn MJ; Peeters PH; Grobbee DE
Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):154-67. PubMed ID: 11006924
[TBL] [Abstract][Full Text] [Related]
15. Soy isoflavones: are they useful in menopause?
Vincent A; Fitzpatrick LA
Mayo Clin Proc; 2000 Nov; 75(11):1174-84. PubMed ID: 11075748
[TBL] [Abstract][Full Text] [Related]
16. The not-soy-good results. Soy protein and isoflavones haven't held up well in clinical trials, but there's still a place for soy in our diets.
Harv Health Lett; 2007 Jun; 32(8):6. PubMed ID: 17639623
[No Abstract] [Full Text] [Related]
17. Soy and cardiovascular disease: cholesterol lowering and beyond.
Anthony MS
J Nutr; 2000 Mar; 130(3):662S-3S. PubMed ID: 10702605
[No Abstract] [Full Text] [Related]
18. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones.
Setchell KD
Am J Clin Nutr; 1998 Dec; 68(6 Suppl):1333S-1346S. PubMed ID: 9848496
[TBL] [Abstract][Full Text] [Related]
19. Isoflavones and postmenopausal women: a critical review.
Phipps WR; Duncan AM; Kurzer MS
Treat Endocrinol; 2002; 1(5):293-311. PubMed ID: 15832484
[TBL] [Abstract][Full Text] [Related]
20. Cellular and physiological effects of soy flavonoids.
Valachovicova T; Slivova V; Sliva D
Mini Rev Med Chem; 2004 Oct; 4(8):881-7. PubMed ID: 15544549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
